CarcinoPred-EL: Novel models for predicting the carcinogenicity of chemicals using molecular fingerprints and ensemble learning methods
暂无分享,去创建一个
Jian Zhao | Qi Zhao | Wen Chen | Li Zhang | Haixin Ai | Zimo Yin | Huan Hu | Junfeng Zhu | Hongsheng Liu | Huan Hu | Li Zhang | Haixin Ai | Qi Zhao | Hongsheng Liu | Jian Zhao | Wen Chen | Junfeng Zhu | Zimo Yin
[1] Cheng Peng,et al. Novel naïve Bayes classification models for predicting the carcinogenicity of chemicals. , 2016, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[2] Xing Chen,et al. Long non-coding RNAs and complex diseases: from experimental results to computational models , 2016, Briefings Bioinform..
[3] Zhu-Hong You,et al. A novel approach based on KATZ measure to predict associations of human microbiota with non‐infectious diseases , 2016, Bioinform..
[4] Jürgen Bajorath,et al. Profile Scaling Increases the Similarity Search Performance of Molecular Fingerprints Containing Numerical Descriptors and Structural Keys , 2003, J. Chem. Inf. Comput. Sci..
[5] Alessandro Giuliani,et al. Alternatives to the carcinogenicity bioassay: in silico methods, and the in vitro and in vivo mutagenicity assays , 2010, Expert opinion on drug metabolism & toxicology.
[6] B. Ames,et al. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[7] K. Nishida,et al. Improvement of carcinogenicity prediction performances based on sensitivity analysis in variable selection of SVM models , 2013, SAR and QSAR in environmental research.
[8] Yoshua Bengio,et al. Random Search for Hyper-Parameter Optimization , 2012, J. Mach. Learn. Res..
[9] Naomi L Kruhlak,et al. Comparison of MC4PC and MDL-QSAR rodent carcinogenicity predictions and the enhancement of predictive performance by combining QSAR models. , 2007, Regulatory toxicology and pharmacology : RTP.
[10] Romualdo Benigni,et al. Predicting the carcinogenicity of chemicals with alternative approaches: recent advances , 2014, Expert opinion on drug metabolism & toxicology.
[11] Andrey A Toropov,et al. CORAL software: prediction of carcinogenicity of drugs by means of the Monte Carlo method. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[12] Kurt Hornik,et al. kernlab - An S4 Package for Kernel Methods in R , 2004 .
[13] Jingtian Hu,et al. Predicting carcinogenicity of organic compounds based on CPDB. , 2015, Chemosphere.
[14] G Zbinden,et al. Toxicological screening. , 1984, Regulatory toxicology and pharmacology : RTP.
[15] A. Jacobs,et al. History of Chronic Toxicity and Animal Carcinogenicity Studies for Pharmaceuticals , 2013, Veterinary pathology.
[16] Jie Shen,et al. admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties , 2012, J. Chem. Inf. Model..
[17] F L Fort,et al. Genotoxic potency in Drosophila melanogaster of selected aromatic amines and polycyclic aromatic hydrocarbons as assayed in the DNA repair test. , 1993, Mutation research.
[18] Wei Xie,et al. Computer-Aided Prediction of Rodent Carcinogenicity by PASS and CISOC-PSCT , 2009 .
[19] Maykel Pérez González,et al. Quantitative structure activity relationship for the computational prediction of nitrocompounds carcinogenicity. , 2006, Toxicology.
[20] David S. Wishart,et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..
[21] Francesca Mattioli,et al. Update of carcinogenicity studies in animals and humans of 535 marketed pharmaceuticals. , 2012, Mutation research.
[22] Romualdo Benigni,et al. The Benigni / Bossa rulebase for mutagenicity and carcinogenicity - a module of Toxtree , 2008 .
[23] J. Aronson,et al. Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature , 2016, BMC Medicine.
[24] Max Kuhn,et al. Building Predictive Models in R Using the caret Package , 2008 .
[25] R. Benigni,et al. Nongenotoxic carcinogenicity of chemicals: mechanisms of action and early recognition through a new set of structural alerts. , 2013, Chemical reviews.
[26] Zhigang Zhou,et al. A QSAR Model of PAHs Carcinogenesis Based on Thermodynamic Stabilities of Biactive Sites , 2003, J. Chem. Inf. Comput. Sci..
[27] Tianqi Chen,et al. XGBoost: A Scalable Tree Boosting System , 2016, KDD.
[28] Andy Liaw,et al. Classification and Regression by randomForest , 2007 .
[29] Kuo-Chen Chou,et al. iPhos-PseEn: Identifying phosphorylation sites in proteins by fusing different pseudo components into an ensemble classifier , 2016, Oncotarget.
[30] Andy Liaw,et al. Extreme Gradient Boosting as a Method for Quantitative Structure-Activity Relationships , 2016, J. Chem. Inf. Model..
[31] CHUN WEI YAP,et al. PaDEL‐descriptor: An open source software to calculate molecular descriptors and fingerprints , 2011, J. Comput. Chem..
[32] Xing Chen,et al. HGIMDA: Heterogeneous graph inference for miRNA-disease association prediction , 2016, Oncotarget.
[33] C. D. De Rosa,et al. Prediction of the health effects of polychlorinated biphenyls (PCBs) and their metabolites using quantitative structure-activity relationship (QSAR). , 2008, Toxicology letters.
[34] J. Dearden. The History and Development of Quantitative Structure-Activity Relationships (QSARs) , 2016 .
[35] Premanjali Rai,et al. Predicting carcinogenicity of diverse chemicals using probabilistic neural network modeling approaches. , 2013, Toxicology and applied pharmacology.
[36] Aboul Ella Hassanien,et al. A Predictive Model for Toxicity Effects Assessment of Biotransformed Hepatic Drugs Using Iterative Sampling Method , 2016, Scientific Reports.
[37] A. Zeileis. Econometric Computing with HC and HAC Covariance Matrix Estimators , 2004 .
[38] Kazutoshi Tanabe,et al. Prediction of carcinogenicity for diverse chemicals based on substructure grouping and SVM modeling , 2010, Molecular Diversity.
[39] Yongdong Zhang,et al. Drug-target interaction prediction: databases, web servers and computational models , 2016, Briefings Bioinform..
[40] R Benigni,et al. Quantitative structure-activity relationships of mutagenic and carcinogenic aromatic amines. , 2000, Chemical reviews.
[41] Chin Yee Liew,et al. Mixed learning algorithms and features ensemble in hepatotoxicity prediction , 2011, J. Comput. Aided Mol. Des..
[42] Ralph Kühne,et al. Quantitative and qualitative models for carcinogenicity prediction for non-congeneric chemicals using CP ANN method for regulatory uses , 2010, Molecular Diversity.
[43] J. Huff,et al. Long‐Term Chemical Carcinogenesis Bioassays Predict Human Cancer Hazards: Issues, Controversies, and Uncertainties , 1999, Annals of the New York Academy of Sciences.
[44] J Ashby,et al. Mutagenicity to Salmonella, Drosophila and the mouse bone marrow of the human antineoplastic agent fotemustine: prediction of carcinogenic potency. , 1993, Mutation research.
[45] Micha Rautenberg,et al. lazar: a modular predictive toxicology framework , 2013, Front. Pharmacol..
[46] Xing Chen,et al. NLLSS: Predicting Synergistic Drug Combinations Based on Semi-supervised Learning , 2016, PLoS Comput. Biol..
[47] Igor V. Tetko,et al. ToxAlerts: A Web Server of Structural Alerts for Toxic Chemicals and Compounds with Potential Adverse Reactions , 2012, J. Chem. Inf. Model..
[48] J. Huff,et al. The carcinogenesis bioassay in perspective: application in identifying human cancer hazards. , 1995, Environmental health perspectives.
[49] Christoph Helma,et al. Lazy structure-activity relationships (lazar) for the prediction of rodent carcinogenicity and Salmonella mutagenicity , 2006, Molecular Diversity.
[50] Ann M Richard,et al. A novel approach: chemical relational databases, and the role of the ISSCAN database on assessing chemical carcinogenicity. , 2008, Annali dell'Istituto superiore di sanita.
[51] Aixia Yan,et al. Carcinogenicity prediction of noncongeneric chemicals by a support vector machine. , 2013, Chemical research in toxicology.
[52] G. Friedman,et al. Screening pharmaceuticals for possible carcinogenic effects: initial positive results for drugs not previously screened , 2009, Cancer Causes & Control.
[53] Zengrui Wu,et al. In Silico Estimation of Chemical Carcinogenicity with Binary and Ternary Classification Methods , 2015, Molecular informatics.
[54] Vladimir B Bajic,et al. In silico toxicology: computational methods for the prediction of chemical toxicity , 2016, Wiley interdisciplinary reviews. Computational molecular science.
[55] Emilio Benfenati,et al. New public QSAR model for carcinogenicity , 2010, Chemistry Central journal.
[56] Emilio Benfenati,et al. New clues on carcinogenicity-related substructures derived from mining two large datasets of chemical compounds , 2016, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.
[57] Matthew D Segall,et al. Addressing toxicity risk when designing and selecting compounds in early drug discovery. , 2014, Drug discovery today.
[58] Adrià Cereto-Massagué,et al. Molecular fingerprint similarity search in virtual screening. , 2015, Methods.
[59] L. Gold,et al. Supplement to the Carcinogenic Potency Database (CPDB): results of animal bioassays published in the general literature through 1997 and by the National Toxicology Program in 1997-1998. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[60] Xing Chen,et al. IRWRLDA: improved random walk with restart for lncRNA-disease association prediction , 2016, Oncotarget.